Yep. I'm in absolute agreement with that, which is why it struck me as odd that it took them so long to make any mention of addressing those markets. GCSF, the interferons, to a lesser extent these days EPO... you've already listed them all. They were all part of the business plans of the lagging fledgling companies 5 years ago.
No major worries; I'm sure there are plenty of products ahead.
News 
Market Data 
Discover 
